MCK Q4 2025 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q4 2025 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$90.8B+18.9% YoY

Gross Profit

$2.9B3.2% margin

Operating Income

$1.0B1.1% margin

Net Income

$1.3B1.4% margin

EPS (Diluted)

$10.01

QoQ Revenue Growth

-4.7%

Cash Flow

Operating Cash Flow

$7.7B

Free Cash Flow

$7.5B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$75.1B

Total Liabilities

$76.8B

Stockholders' Equity

-$2.1B

Cash & Equivalents

$5.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$90.8B	$76.4B	+18.9%
Gross Profit	$2.9B	$3.5B	-15.7%
Operating Income	$1.0B	$1.4B	-24.5%
Net Income	$1.3B	$791M	+59.3%

Revenue Segments

U.S. Pharmaceutical Segment

$83.2B92%

International Segment

$3.5B4%

Medical-Surgical Solutions Segment

$2.9B3%

Prescription Technology Solutions

$1.3B1%